ES2146275T3 - Derivados de camptotecina, preparaciones de los mismos y agentes antitumorales. - Google Patents

Derivados de camptotecina, preparaciones de los mismos y agentes antitumorales.

Info

Publication number
ES2146275T3
ES2146275T3 ES95113931T ES95113931T ES2146275T3 ES 2146275 T3 ES2146275 T3 ES 2146275T3 ES 95113931 T ES95113931 T ES 95113931T ES 95113931 T ES95113931 T ES 95113931T ES 2146275 T3 ES2146275 T3 ES 2146275T3
Authority
ES
Spain
Prior art keywords
sub
sup
hydrogen
preparations
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95113931T
Other languages
English (en)
Inventor
Takashi Yaegashi
Seigo Sawada
Tomio Furuta
Teruo Yokokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Yakult Honsha Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2146275T3 publication Critical patent/ES2146275T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE CAMPTOTECINA DE LA FORMULA GENERAL (1), PREPARACIONES DE LOS MISMOS Y AGENTES ANTITUMORES QUE LOS CONTIENEN, EN LA QUE R{SUP,1} REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C{SUB,1}-C{SUB,6}, R{SUP,2} REPRESENTA UN HIDROGENO O UN GRUPO ALCOXI C{SUB,1}-C{SUB,6}, R{SUP,3} REPRESENTA UN ATOMO DE HIDROGENO O DE HALOGENO O UN GRUPO ALQUILO C{SUB,1}-C{SUB,6}, ALCOXI C{SUB,1}-C{SUB,6}, HIDROXILO, ACILOXI C{SUB,2}-C{SUB,6} O METOXIETOXIMETOXI, R{SUP,4} REPRESENTA UN ATOMO DE HIDROGENO O DE HALOGENO, Y R{SUP,5} REPRESENTA UN GRUPO ALQUILO C{SUB,1}C{SUB,6}, ALQUILO INSATURADO C{SUB,3}-C{SUB,6}, ALQUILTIOALQUILO, ALCOXIALQUILO, PIRIDILO O FENILO SUSTITUIDO, CON LA CONDICION DE QUE TODOS LOS R{SUP,2}, R{SUP,3} Y R{SUP,4} NO SEAN UN ATOMO DE HIDROGENO.
ES95113931T 1994-09-06 1995-09-05 Derivados de camptotecina, preparaciones de los mismos y agentes antitumorales. Expired - Lifetime ES2146275T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6246660A JPH0873461A (ja) 1994-09-06 1994-09-06 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤

Publications (1)

Publication Number Publication Date
ES2146275T3 true ES2146275T3 (es) 2000-08-01

Family

ID=17151729

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95113931T Expired - Lifetime ES2146275T3 (es) 1994-09-06 1995-09-05 Derivados de camptotecina, preparaciones de los mismos y agentes antitumorales.

Country Status (17)

Country Link
US (1) US5843954A (es)
EP (1) EP0700914B1 (es)
JP (1) JPH0873461A (es)
KR (1) KR100351952B1 (es)
CN (1) CN1052482C (es)
AT (1) ATE192447T1 (es)
AU (1) AU688547B2 (es)
CA (1) CA2157128C (es)
DE (1) DE69516605T2 (es)
DK (1) DK0700914T3 (es)
ES (1) ES2146275T3 (es)
GR (1) GR3033798T3 (es)
IL (1) IL114989A (es)
NZ (1) NZ272904A (es)
PT (1) PT700914E (es)
RU (1) RU2133748C1 (es)
ZA (1) ZA957269B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AR027687A1 (es) 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
ITMI20051348A1 (it) * 2005-07-14 2007-01-15 Indena Spa Analoghi della camptotecina loro processo di ottenimento loro uso e formulazioni che li contengono
CN100339377C (zh) * 2005-09-05 2007-09-26 合肥中科大生物技术有限公司 喜树碱衍生物及其制备
CN1319971C (zh) * 2005-09-09 2007-06-06 合肥中科大生物技术有限公司 喜树碱衍生物及其用途
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
US11814394B2 (en) 2021-11-16 2023-11-14 Genequantum Healthcare (Suzhou) Co., Ltd. Exatecan derivatives, linker-payloads, and conjugates and thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5839684A (ja) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd １０−置換カンプテシン誘導体の製造法
JPS5951287A (ja) * 1982-09-17 1984-03-24 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5122606A (en) * 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US5049668A (en) * 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
JP2540357B2 (ja) * 1987-06-24 1996-10-02 第一製薬株式会社 六環性化合物
CA1332413C (en) * 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JP2538792B2 (ja) 1987-06-25 1996-10-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
WO1991004260A2 (en) * 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
US5162532A (en) * 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs

Also Published As

Publication number Publication date
IL114989A0 (en) 1995-12-08
EP0700914B1 (en) 2000-05-03
DK0700914T3 (da) 2000-07-31
KR100351952B1 (ko) 2002-12-28
CA2157128C (en) 2006-04-11
DE69516605D1 (de) 2000-06-08
NZ272904A (en) 1996-08-27
CA2157128A1 (en) 1996-03-07
EP0700914A1 (en) 1996-03-13
AU688547B2 (en) 1998-03-12
US5843954A (en) 1998-12-01
ZA957269B (en) 1996-03-25
PT700914E (pt) 2000-09-29
CN1052482C (zh) 2000-05-17
DE69516605T2 (de) 2000-10-26
JPH0873461A (ja) 1996-03-19
RU2133748C1 (ru) 1999-07-27
KR960010644A (ko) 1996-04-20
GR3033798T3 (en) 2000-10-31
IL114989A (en) 1998-09-24
ATE192447T1 (de) 2000-05-15
AU3047495A (en) 1996-03-21
CN1126212A (zh) 1996-07-10

Similar Documents

Publication Publication Date Title
ES2140075T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
BG43866A3 (en) Method for preparing of derivatives of 2, 2'- imino- bis- ethanol
FI843522A0 (fi) 1-heteroaryl-4/2,5-pyrrolidindion-1-yl) alkyl/piperazinderivat.
ES2037055T3 (es) Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas.
ES2146275T3 (es) Derivados de camptotecina, preparaciones de los mismos y agentes antitumorales.
DE3481168D1 (de) Sebosuppressive kosmetische mittel, enthaltend benzylalkohol-derivate.
ES2084062T3 (es) Nuevos derivados de bis(4-(2,6-di-alquil)fenol)silano como agentes antiateroescleroticos y como antioxidantes.
GR1000355B (el) Μεθοδος παρασκευης 2-υποκατεστημενων ν,ν-διτριμεθοξυβενζουλοπιπεραζινων.
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
ATE102041T1 (de) Ghilanten: antimetastatischer wirkstoff aus dem suedamerikanischen blutegel haementeria ghilianii.
DK299584A (da) Hidtil ukendte prostacyklinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
NO158016C (no) Fremgangsmaate for fremstilling av (-)-2-(1-(2,6-diklor-fenoksy)-etyl)-1,3-diazacyklopent-2-en.
DE59308900D1 (de) (-)-metrifonat enthaltendes arzneimittel
ES2073502T3 (es) Derivados de isoquinolina y sus sales como inhibidores de la proteasa.
EP0230226A3 (en) Antimycotic emulsions
KR830006257A (ko) 페닐 피페라진 유도체의 제조방법
NO158095C (no) Fremgangsmaate for nitrering av metanol.
ES2140776T3 (es) Derivados de ciclopentadienilo puenteados y procedimiento para su preparacion.
ES8504174A1 (es) Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.
ES2051876T3 (es) Procedimiento para preparar derivados de la 1-bencenosulfonil-2-oxo-5-alquiltio-pirrolidina.
SE8103822L (sv) Antiarytmiskt medel
IT8123171A0 (it) Stabilizzazione di dispersioni disodio.
SE8405317L (sv) Anordning for bekempning av markmal
SE8103552L (sv) Lockvikanordning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 700914

Country of ref document: ES